Explore curated funding opportunities for UMass Amherst researchers.
Mussallem CHD Blue-Sky Therapeutics RFP
Funder Deadline: 08/17/2026 (LOI); 11/09/2026 (Full Application)
Amount: Up to $350,000
Focus: Early-stage, high-risk, non-device therapeutic innovation for congenital heart defects
Implementation Awards
Funder Deadline: 09/09/2026 (LOI); 01/12/2027 (Full application)
Amount: Up to $1.8 Million
Focus: Projects that aim to implement patient-centered CER results obtained from PCORI-funded research in real-world practice settings, and in selected cases, projects that focus on planning for implementation of these findings or on the dissemination of these findings.
Grants Program
Funder Deadline: 09/15/2026
Amount: Unspecified
Focus: Architecture and related fields.
Senior Fellowship
Funder Deadline: 09/15/2026
Amount: Up to $30,000
Focus: Critical and historical studies related to painting, sculpture and allied arts from the twentieth century.
Note: Applicants must be citizens of the United States.
Fast Grants Program
Funder Deadline: 12/15/2026
Amount: Up to $100,000
Focus: AI and health.
New Investigator Grant
Funder Deadline: 09/15/2026
Amount: $200,000
Focus: Research related to Scleroderma.
Note: Applicants must have a doctoral degree in Medicine, Osteopathy, Veterinary Medicine, or one of the sciences + view additional awards.
Bruce and Jane Walsh Grant in Memory of John Holland
Funder Deadline: 09/18/2026
Amount: $19,000
Focus: How personality, culture, and environment influence work behavior and health (mental and physical).
Fellowship Program
Funder Deadline: 09/10/2026 (Humanities, social sciences, etc.); 10/01/2026 (Science, engineering, and mathematics)
Amount: $78,000 + $5,000 for project expenses.
Focus: pressing social, scientific, and policy issues.
Targeted Grants to Institutes
Funder Deadline: 09/30/2026
Amount: Up to $750,000
Focus: Mathematics and theoretical basic physical sciences.
Established Investigator Grant
Funder Deadline: 09/15/2026
Amount: $200,000
Focus: Research related to scleroderma that will culminate in more substantial funding from Federal or non-federal granting agencies.
Note: Applicant must have been principal investigator on grants from the National Scleroderma Foundation or other national, private or government agencies in the past + view additional awards.